Thiosemicarbazone derivatives have also been employed as NDRG1 up-regulators, cathepsin inhibitors, and cholinesterase inhibitors for the treatment of Alzheimer’s disease [35,36,37,38]. Here, BCHE is linked to early-onset autosomal dominant Alzheimer disease.